These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 8414500
1. Rb may act as a transcriptional co-activator in undifferentiated F9 cells. Bocco JL, Reimund B, Chatton B, Kedinger C. Oncogene; 1993 Nov; 8(11):2977-86. PubMed ID: 8414500 [Abstract] [Full Text] [Related]
2. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein. Mannervik M, Fan S, Ström AC, Helin K, Akusjärvi G. Virology; 1999 Apr 10; 256(2):313-21. PubMed ID: 10191196 [Abstract] [Full Text] [Related]
3. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation. Kirch HC, Pützer B, Schwabe G, Gnauck HK, Schulte Holthausen H. Cell Mol Biol Res; 1993 Apr 10; 39(8):705-16. PubMed ID: 7951410 [Abstract] [Full Text] [Related]
4. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oswald F, Lovec H, Möröy T, Lipp M. Oncogene; 1994 Jul 10; 9(7):2029-36. PubMed ID: 8208548 [Abstract] [Full Text] [Related]
5. A new component of the transcription factor DRTF1/E2F. Girling R, Partridge JF, Bandara LR, Burden N, Totty NF, Hsuan JJ, La Thangue NB. Nature; 1993 Mar 04; 362(6415):83-7. PubMed ID: 8446173 [Abstract] [Full Text] [Related]
6. Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site. Ouellette MM, Chen J, Wright WE, Shay JW. Oncogene; 1992 Jun 04; 7(6):1075-81. PubMed ID: 1534398 [Abstract] [Full Text] [Related]
7. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter. Rotheneder H, Geymayer S, Haidweger E. J Mol Biol; 1999 Nov 12; 293(5):1005-15. PubMed ID: 10547281 [Abstract] [Full Text] [Related]
8. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters. O'Connor RJ, Schaley JE, Feeney G, Hearing P. Oncogene; 2001 Apr 05; 20(15):1882-91. PubMed ID: 11313936 [Abstract] [Full Text] [Related]
9. Retinoblastoma protein recruits histone deacetylase to repress transcription. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. Nature; 1998 Feb 05; 391(6667):597-601. PubMed ID: 9468139 [Abstract] [Full Text] [Related]
10. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Bandara LR, La Thangue NB. Nature; 1991 Jun 06; 351(6326):494-7. PubMed ID: 1710781 [Abstract] [Full Text] [Related]
12. Functional interplay between p53 and E2F through co-activator p300. Lee CW, Sørensen TS, Shikama N, La Thangue NB. Oncogene; 1998 May 28; 16(21):2695-710. PubMed ID: 9652736 [Abstract] [Full Text] [Related]
13. Characterization of an E2F-p130 complex formed during growth arrest. Corbeil HB, Branton PE. Oncogene; 1997 Aug 07; 15(6):657-68. PubMed ID: 9264406 [Abstract] [Full Text] [Related]
14. Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen. Batsché E, Lipp M, Cremisi C. Oncogene; 1994 Aug 07; 9(8):2235-43. PubMed ID: 8036009 [Abstract] [Full Text] [Related]
16. Isolation and initial characterization of the BRCA2 promoter. Davis PL, Miron A, Andersen LM, Iglehart JD, Marks JR. Oncogene; 1999 Oct 28; 18(44):6000-12. PubMed ID: 10557089 [Abstract] [Full Text] [Related]
17. Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome. Swaminathan S, Thimmapaya B. J Mol Biol; 1996 May 24; 258(5):736-46. PubMed ID: 8637006 [Abstract] [Full Text] [Related]
18. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1. Darbinian N, Gallia GL, Kundu M, Shcherbik N, Tretiakova A, Giordano A, Khalili K. Oncogene; 1999 Nov 04; 18(46):6398-402. PubMed ID: 10597240 [Abstract] [Full Text] [Related]
19. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy. Jakubczak JL, Ryan P, Gorziglia M, Clarke L, Hawkins LK, Hay C, Huang Y, Kaloss M, Marinov A, Phipps S, Pinkstaff A, Shirley P, Skripchenko Y, Stewart D, Forry-Schaudies S, Hallenbeck PL. Cancer Res; 2003 Apr 01; 63(7):1490-9. PubMed ID: 12670895 [Abstract] [Full Text] [Related]